<code id='390F6DEA2C'></code><style id='390F6DEA2C'></style>
    • <acronym id='390F6DEA2C'></acronym>
      <center id='390F6DEA2C'><center id='390F6DEA2C'><tfoot id='390F6DEA2C'></tfoot></center><abbr id='390F6DEA2C'><dir id='390F6DEA2C'><tfoot id='390F6DEA2C'></tfoot><noframes id='390F6DEA2C'>

    • <optgroup id='390F6DEA2C'><strike id='390F6DEA2C'><sup id='390F6DEA2C'></sup></strike><code id='390F6DEA2C'></code></optgroup>
        1. <b id='390F6DEA2C'><label id='390F6DEA2C'><select id='390F6DEA2C'><dt id='390F6DEA2C'><span id='390F6DEA2C'></span></dt></select></label></b><u id='390F6DEA2C'></u>
          <i id='390F6DEA2C'><strike id='390F6DEA2C'><tt id='390F6DEA2C'><pre id='390F6DEA2C'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:explore    Page View:123
          People taking notes while sitting around a meeting table
          Adobe

          It makes sense in theory for hospitals and startups to strike deals. Not only would doctors get first dibs on new health care technologies, their organizations would see windfalls if those startups hit it big.

          In practice, it often doesn’t work out that way. Doctors and other clinicians have their own way of doing things, and they typically don’t take kindly to an administrator telling them to learn a new product, especially if the goal is financial gain.

          advertisement

          Several health system-venture capital arrangements have fallen victim to this dynamic — but VC firm General Catalyst said this week it will buy nonprofit Summa Health, anyway.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more
          Diversifying clinical trials isn't enough to close racial gaps: study
          Diversifying clinical trials isn't enough to close racial gaps: study

          AdobeParticipationinaclinicaltrialisoftenconsideredsomethingofanequalizerinmedicine.Researchershavep

          read more
          In Memoriam: Notable people who died in 2023
          In Memoriam: Notable people who died in 2023

          1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

          read more

          Meta's Zuckerberg and Chan on track to put $50 billion into science

          PriscillaChanandMarkZuckerbergonstage,virtually,atthe2023STATSummit.STATMarkZuckerbergandPriscillaCh